Twitxy
Saved
@GenSightBio's profile picture
View on X

GenSight Biologics

@GenSightBio

A clinical-stage biotechnology company developing novel therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system.
Paris, France gensight-biologics.com Joined May 2016
97 Following 1.7K Followers 484 Posts

Latest posts 5

GenSight Biologics @GenSightBio
GenSight Biologics Announces Publication of Non-Human Primate Study Reporting Presence of LUMEVOQ® Vector DNA in Contralateral Eyes After Unilateral Injection | Business Wire
businesswire.com/news/home/2021…
www.businesswire.com GenSight Biologics Announces Publication of Non-Human Primate Study Reporting Presence of LUMEVOQ®... Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing in...
GenSight Biologics @GenSightBio
GenSight Biologics reports second patient case showing significant visual recovery after GS030 optogenetic treatment in the PIONEER Phase I/II trial
Patient video on vimeo.com/646472992

#Optogenetics #Ophthalmology #retinitis #blindness #AAO2021
vimeo.com PIONEER Patient 2 - visual recovery after GS030 treatment This is "PIONEER Patient 2 - visual recovery after GS030 treatment" by GenSight Biologics on Vimeo, the home for high quality videos and the people who love them.